FDA Leader Talks Cellular Therapy With Sanford Health
Guest User Guest User

FDA Leader Talks Cellular Therapy With Sanford Health

Orthobiologics can refer to a variety of treatment options based on a patient’s specific needs. These treatments are relatively new, so oversight is important to make sure patients are getting the best care.

Peter Marks, M.D., Ph.D., is the director of the Center for Biologics, Evaluation and Research at the Food and Drug Administration in Washington, D.C. He helps manage the regulation of complex biologic products, including cell and gene therapies, blood products and vaccines.

Read More